-
Tata India Pharma & Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 24/04/25 )
NAV
₹29.78
Last change
₹0.15 +0.01%
Fund Size (AUM)
1183.65 Cr
Performance
22.12% (5Y)
Fund Details
Tata India Pharma & Healthcare Fund Regular Growth
as of 24/04/25
AUM
1183.65 Cr
Expense Ratio
2.17 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K016A9
Fund Manager
Meeta Shetty
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular Growth | 20.27% | 20.31% | 22.12% |
| Nifty Pharma TR INR | 18.17% | 19.45% | 27.8% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.79% |
Aurobindo Pharma Ltd |
7.27% |
Cipla Ltd |
5.97% |
Apollo Hospitals Enterprise Ltd |
5.66% |
Lupin Ltd |
5.2% |
Divi's Laboratories Ltd |
5.12% |
Fortis Healthcare Ltd |
5.05% |
Aster DM Healthcare Ltd Ordinary Shares |
3.91% |
Dr Reddy's Laboratories Ltd |
3.5% |
Wockhardt Ltd |
3.31% |
Sector Allocation
Healthcare |
97.56% |
Basic Materials |
2.44% |
Asset Allocation
-
96%
Equity
-
4%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
25.41% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
25.31% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
25.31% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
22.65% (5Y)
-
-
UTI Healthcare Reg Gr
Equity healthcare-
Returns
-
22.21% (5Y)
-
-
UTI Healthcare Reg IDCW-P
Equity healthcare-
Returns
-
22.21% (5Y)
-
